HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Antonio Rosato Selected Research
Antonio Rosato Research Topics
Disease
90
Neoplasms (Cancer)
04/2024 - 02/2002
15
Melanoma (Melanoma, Malignant)
03/2024 - 08/2009
13
Infections
11/2022 - 04/2004
12
Breast Neoplasms (Breast Cancer)
11/2023 - 02/2005
10
Neoplasm Metastasis (Metastasis)
03/2023 - 04/2009
6
Inflammation (Inflammations)
01/2023 - 12/2006
5
Prostatic Neoplasms (Prostate Cancer)
12/2023 - 01/2020
5
Carcinoma (Carcinomatosis)
01/2017 - 01/2006
4
Triple Negative Breast Neoplasms
10/2022 - 01/2016
4
Adenocarcinoma
04/2022 - 05/2003
3
Sarcoma (Soft Tissue Sarcoma)
01/2023 - 11/2009
3
COVID-19
01/2023 - 01/2022
3
Lymphoma (Lymphomas)
01/2020 - 02/2002
3
Carcinogenesis
01/2020 - 01/2006
3
Hepatocellular Carcinoma (Hepatoma)
05/2017 - 02/2005
3
Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 06/2008
3
Urinary Bladder Neoplasms (Bladder Cancer)
10/2013 - 05/2006
3
Menkes Kinky Hair Syndrome (Menkes Disease)
09/2006 - 02/2005
2
Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 01/2022
2
Colitis
01/2023 - 12/2013
2
Communicable Diseases (Infectious Diseases)
06/2022 - 11/2016
2
Hepatolenticular Degeneration (Wilson's Disease)
01/2019 - 08/2009
2
Nasopharyngeal Carcinoma
01/2016 - 09/2009
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2024
1
Carcinoma in Situ
04/2024
1
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
04/2024
1
Myeloid Leukemia (Leukemia, Myelocytic)
10/2023
1
Transient Myeloproliferative Syndrome
10/2023
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2023
Drug/Important Bio-Agent (IBA)
26
Proteins (Proteins, Gene)
FDA Link
10/2022 - 05/2003
16
Antigens
IBA
12/2023 - 02/2002
9
Hyaluronic Acid (Hyaluronan)
IBA
04/2024 - 05/2006
7
Peptides (Polypeptides)
IBA
12/2023 - 05/2003
7
Monoclonal Antibodies
IBA
11/2023 - 08/2016
6
Paclitaxel (Taxol)
FDA Link
Generic
04/2024 - 05/2006
5
Immune Checkpoint Inhibitors
IBA
03/2023 - 05/2021
5
Chimeric Antigen Receptors
IBA
01/2023 - 03/2011
5
Cytokines
IBA
01/2023 - 12/2009
5
Messenger RNA (mRNA)
IBA
01/2023 - 10/2006
5
Survivin
IBA
02/2013 - 01/2006
4
Vaccines
IBA
01/2023 - 02/2006
4
Anti-Bacterial Agents (Antibiotics)
IBA
11/2022 - 11/2007
4
Biomarkers (Surrogate Marker)
IBA
09/2022 - 01/2016
4
Epitopes
IBA
01/2017 - 02/2002
3
Radiopharmaceuticals
IBA
12/2023 - 08/2009
3
Cetuximab (Erbitux)
FDA Link
11/2023 - 08/2016
3
Nivolumab
IBA
01/2023 - 01/2020
3
Trastuzumab (Herceptin)
FDA Link
04/2022 - 08/2016
3
DNA (Deoxyribonucleic Acid)
IBA
04/2022 - 02/2006
3
Radioisotopes (Radionuclides)
IBA
03/2022 - 08/2009
3
Zinc
IBA
01/2022 - 11/2014
3
Doxorubicin (Adriamycin)
FDA Link
Generic
05/2017 - 02/2002
3
Solutions
IBA
08/2009 - 02/2005
2
obinutuzumab
IBA
05/2024 - 01/2021
2
ONCOFID-P
IBA
04/2024 - 06/2008
2
Circulating Tumor DNA
IBA
03/2024 - 12/2021
2
Anti-Infective Agents (Microbicides)
IBA
11/2023 - 07/2021
2
Glycoproteins (Glycoprotein)
IBA
01/2023 - 01/2021
2
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
06/2022 - 06/2021
2
Formaldehyde (Formol)
FDA Link
04/2022 - 11/2020
2
Paraffin
IBA
04/2022 - 11/2020
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022 - 08/2012
2
Volatile Oils (Essential Oils)
IBA
06/2021 - 11/2007
2
Neoplasm Antigens (Tumor Antigens)
IBA
01/2021 - 08/2016
2
Micelles
IBA
12/2020 - 01/2017
2
Interferons
IBA
11/2020 - 11/2016
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
11/2020 - 12/2009
2
Antibodies
IBA
11/2020 - 08/2016
2
MicroRNAs (MicroRNA)
IBA
01/2018 - 06/2010
2
MC3181
IBA
02/2017 - 02/2015
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2017 - 01/2016
2
Peptidylprolyl Isomerase (Prolyl Isomerase)
IBA
01/2017 - 02/2009
2
Biocompatible Materials (Biomaterials)
IBA
03/2016 - 12/2013
2
Glutathione Transferase (Glutathione S-Transferase)
IBA
02/2015 - 09/2009
2
Irinotecan (Camptosar)
FDA Link
Generic
01/2015 - 01/2014
2
Caspase 3 (Caspase-3)
IBA
01/2015 - 01/2006
2
Acids
IBA
12/2013 - 08/2009
2
Caspases
IBA
10/2013 - 02/2002
2
Hyaluronan Receptors
IBA
07/2008 - 02/2007
2
Boron
IBA
07/2008 - 02/2007
2
Copper
IBA
09/2005 - 02/2005
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
03/2024
1
Immunoglobulin G (IgG)
IBA
12/2023
1
Single-Chain Antibodies
IBA
12/2023
1
Panitumumab (Vectibix)
FDA Link
11/2023
1
ErbB Receptors (EGF Receptor)
IBA
11/2023
1
phthalimide
IBA
11/2023
1
benzothiazole
IBA
11/2023
1
Transglutaminases
IBA
10/2023
1
Cohesins
IBA
10/2023
1
Small Cytoplasmic RNA
IBA
10/2023
1
Codon (Codons)
IBA
07/2023
Therapy/Procedure
30
Therapeutics
04/2024 - 02/2007
15
Immunotherapy
01/2023 - 05/2003
6
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023 - 06/2007
3
Precision Medicine
10/2023 - 01/2020
2
Biological Therapy
01/2022 - 01/2022
1
Intravesical Administration
04/2024
1
Cell Transplantation
04/2024
1
Aftercare (After-Treatment)
10/2023